Masahiro Toide
Papers
15
Total Citations
81
H-Index
5
About
Masahiro Toide is a leading urological surgeon and researcher whose work centers on improving outcomes for prostate cancer patients undergoing robot-assisted radical prostatectomy (RARP). As a key member of the MSUG94 group, Toide has spearheaded large-scale, multicenter retrospective cohort studies across Japan that have reshaped clinical decision-making in robotic surgery. His most impactful contribution challenges the routine use of pelvic lymphadenectomy, demonstrating that it may not improve biochemical recurrence-free survival—a finding with direct implications for reducing surgical morbidity. Toide has also developed predictive nomograms for lymph node involvement and identified prognostic factors such as positive surgical margin locations, lymphovascular invasion, and inflammation-related parameters. With over 70 citations across his top papers, his work provides critical evidence on oncological outcomes, complication risks like inguinal hernia, and the influence of hospital volume on surgical quality. By systematically analyzing the nuances of Grade Group 4 subgroups and seminal vesicle invasion, Toide continues to refine risk stratification and personalize treatment for prostate cancer patients in the robotic surgery era.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10